Patents by Inventor Peter Sinclair

Peter Sinclair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10439832
    Abstract: Systems, methods, and software are disclosed herein for enhancing ad-hoc online meetings. A service client, when executed by a computing system, directs the computing system to at least detect an in-room discovery signal, identify a room from the in-room discovery signal, identify a session based on the room associated with the in-room discovery signal, and join the session.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: October 8, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Ross Garrett Cutler, Andrew Peter Sinclair, Jonathan Adam Kauffman, Anton Krantz
  • Patent number: 10432676
    Abstract: Non-limiting examples disclosed herein describe processing capabilities for ad-hoc online meetings. In an implementation, an identifier is received that corresponds with a specific location. A proximity signal is received from one or more components associated with the specific location. The received proximity signal comprises one of: a modulated light signal, an audible sound, an inaudible sound and ambient noise. The identifier is validated based on a comparison of the proximity signal with a reference signal for the one or more components. A service identifier for a conferencing session is provided based on a validation of the identifier. In one example, a computing device is connected to the conference session based on receipt of a request that comprises the provided service identifier. In another example, the conference session is automatically transferred from a client computing device to a component associated with the specific location such as a room display device.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: October 1, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Ross Garrett Cutler, Andrew Peter Sinclair, Jonathan Adam Kauffman, Anton Krantz
  • Patent number: 10421733
    Abstract: Methods of synthesizing and purifying certain 3,7-diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (also known as Methylene Blue) are provided.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: September 24, 2019
    Assignee: WISTA LABORATORIES LTD.
    Inventors: James Peter Sinclair, Sarah Louise Nicoll, John Mervyn David Storey
  • Publication number: 20190198283
    Abstract: An apparatus may include an electrode assembly, the electrode assembly comprising a plurality of electrodes, arranged in a plurality of electrode pairs arranged to conduct an ion beam therethrough. A given electrode pair lies along a radius of an arc describing a nominal central ray trajectory, wherein a radius of a first electrode pair and an adjacent electrode pair define an angular spacing. The plurality of electrode pairs may define a plurality of angular spacings, wherein, in a first configuration, the plurality of angular spacings are not all equal. The apparatus may also include a power supply in communication with the EM, the power supply configured to independently supply voltage to the plurality of electrodes.
    Type: Application
    Filed: April 9, 2018
    Publication date: June 27, 2019
    Applicant: Varian Semiconductor Equipment Associates, Inc.
    Inventors: Svetlana Radovanov, Ana Samolov, Shengwu Chang, Frank Sinclair, Peter L. Kellerman
  • Patent number: 10323010
    Abstract: The present invention pertains generally to the field of chemical synthesis, and more particularly to methods of chemical synthesis which include the step of preparing a substituted 10H-phenothiazine-3,7-diamine compound of Formula (1) by a step of selective alkylation by reductive amination, in which the corresponding unsubstituted diamine of Formula (4) is reacted with aldehyde/ketone, under reductive amination conditions. The present invention also relates to such methods which incorporate additional subsequent and/or preceding steps, for example, to prepare compounds of Formulae (2) and (3) from compounds of Formula (1), and to prepare compounds of Formula (4) from, for example, compounds of Formulae (5), (6), (7), (8), and (9). Compounds of Formula (1), Formula (2), and Formula (3) are useful, for example, in the treatment of diseases of protein aggregation, such as Alzheimer's disease.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: June 18, 2019
    Assignee: WISTA LABORATORIES LTD.
    Inventors: John Mervyn David Storey, Christopher Paul Larch, Steven John Kemp, Scott Clunas, Sarah Louise Nicoll, Helen Sarah Gibbard, Michael Simpson, James Peter Sinclair, Colin Marshall
  • Patent number: 10296861
    Abstract: Disclosed herein are systems, methods, and software to enhance meeting technology. In an implementation, a meetings graph may be generated for a meeting between various participants in the meeting. An effectiveness of the meeting may be identified based at least in part on a comparison of the meetings graph to a model meetings graph for a model meeting. An indication of the effectiveness of the meeting may then be communicated to at least an application for surfacing in a user interface to the application.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: May 21, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Anton Krantz, Ross Garrett Cutler, Andrew Peter Sinclair, Jonathan Adam Kauffman
  • Publication number: 20190046537
    Abstract: Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.
    Type: Application
    Filed: March 5, 2018
    Publication date: February 14, 2019
    Applicant: WisTa Laboratories Ltd.
    Inventors: Colin Marshall, Scott Clunas, John Mervyn David Storey, James Peter Sinclair, Thomas Craven Baddeley, Ahtsham Ishaq, Michael Simpson, Craig Williamson, Barry Alan Wood, Claude Michel Wischik, Charles Robert Harrington, Janet Elizabeth Rickard, David Horsley, Yin Sze Loh, Karrar Ahmad Khan, Christopher Paul Larch
  • Publication number: 20180327372
    Abstract: Methods of synthesizing and purifying certain 3,7-diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue) are provided.
    Type: Application
    Filed: July 20, 2018
    Publication date: November 15, 2018
    Applicant: WISTA LABORATORIES LTD.
    Inventors: James Peter SINCLAIR, Sarah Louise NICOLL, John Mervyn David STOREY
  • Publication number: 20180263999
    Abstract: Disclosed are methods of synthesis and/or purification of certain 3,7-diamino-phenothiazin-5-ium compounds (“diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (Methylene Blue), and the resulting high purity characterized by a purity greater than 98%, and very low levels of heavy metals and organic impurities Azure A, B, C and MVB. Also disclosed are methods of treatment of a tauopathy or methemoglobinemia in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of the high-purity diaminophenothiazinium compound.
    Type: Application
    Filed: May 23, 2018
    Publication date: September 20, 2018
    Applicant: WISTA LABORATORIES LTD.
    Inventors: Claude Michel WISCHIK, John Mervyn David STOREY, Colin MARSHALL, James Peter SINCLAIR, Thomas Craven BADDELEY
  • Patent number: 10047062
    Abstract: Methods of synthesizing and purifying certain 3,7-diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue) are provided.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: August 14, 2018
    Assignee: WISTA LABORATORIES LTD.
    Inventors: James Peter Sinclair, Sarah Louise Nicoll, John Mervyn David Storey
  • Publication number: 20180208565
    Abstract: The present invention pertains generally to the field of chemical synthesis, and more particularly to methods of chemical synthesis which include the step of preparing a substituted 10H-phenothiazine-3,7-diamine compound of Formula (1) by a step of selective alkylation by reductive amination, in which the corresponding unsubstituted diamine of Formula (4) is reacted with aldehyde/ketone, under reductive amination conditions. The present invention also relates to such methods which incorporate additional subsequent and/or preceding steps, for example, to prepare compounds of Formulae (2) and (3) from compounds of Formula (1), and to prepare compounds of Formula (4) from, for example, compounds of Formulae (5), (6), (7), (8), and (9). Compounds of Formula (1), Formula (2), and Formula (3) are useful, for example, in the treatment of diseases of protein aggregation, such as Alzheimer's disease.
    Type: Application
    Filed: July 20, 2016
    Publication date: July 26, 2018
    Applicant: WisTa Laboratories Ltd.
    Inventors: John Mervyn David STOREY, Christopher Paul LARCH, Steven John KEMP, Scott CLUNAS, Sarah Louise NICOLL, Helen Sarah GIBBARD, Michael SIMPSON, James Peter SINCLAIR, Colin MARSHALL
  • Patent number: 9984443
    Abstract: A camera for polarimetric, multispectral imaging is described. Such cameras are used in photonics, computational imaging and multispectral imaging in which both multispectral and polarimetric sensing modalities are used simultaneously for detection, recognition and identification. The camera enables multiple spectral images to be recorded simultaneously using polarizing beamsplitters and mirrors to divide the image according polarimetric and spectral bands. These multiple, polarized images are recorded on a single focal plane array (FPA) simultaneously. An image processor allows for the resolution of the subsequent image to be improved.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: May 29, 2018
    Assignee: LEONARDO MW LTD
    Inventors: Roger Malcolm Pilkington, Gerald Wong, Robert A. Lamb, Peter Sinclair
  • Patent number: 9980971
    Abstract: Disclosed are methods of synthesis and/or purification of certain 3,7-diamino-phenothiazin-5-ium compounds (“diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (Methylene Blue), and the resulting high purity characterized by a purity greater than 98%, and very low levels of heavy metals and organic impurities Azure A, B, C and MVB. Also disclosed are methods of treatment of a tauopathy or methemoglobinemia in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of the high-purity diaminophenothiazinium compound.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: May 29, 2018
    Assignee: WISTA LABORATORIES LTD.
    Inventors: Claude Michel Wischik, John Mervyn David Storey, Colin Marshall, James Peter Sinclair, Thomas Craven Baddeley
  • Publication number: 20180115432
    Abstract: Systems, methods, and software are disclosed herein for enhancing ad-hoc online meetings. A service client, when executed by a computing system, directs the computing system to at least detect an in-room discovery signal, identify a room from the in-room discovery signal, identify a session based on the room associated with the in-room discovery signal, and join the session.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 26, 2018
    Inventors: Ross Garrett Cutler, Andrew Peter Sinclair, Jonathan Adam Kauffman, Anton Krantz
  • Publication number: 20180078562
    Abstract: This disclosure pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7 diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiaziniumcompounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (NOS); nitrosyl reduction (NR); thiosulfonic acid formation (TSAF); oxidative coupling (OC); Cr(VI) reduction (CR); isolation and purification of zwitterionic intermediate (IAPOZI); ring closure (RC); chloride salt-formation (CSF); one of: sulphide treatment (ST); dimethyldithiocarbamate treatment (DT); carbonate treatment (CT); ethylenediaminetetraacetic acid treatment (EDTAT); organic extraction (OE); and recrystallisation (RX). Also disclosed resulting (high purity) compounds, compositions comprising them (e.g.
    Type: Application
    Filed: September 28, 2017
    Publication date: March 22, 2018
    Applicant: WisTa Laboratories Ltd.
    Inventors: John Mervyn David STOREY, James Peter SINCLAIR, Colin MARSHALL, Han Wan TAN, Claude Michel WISCHIK
  • Patent number: 9907804
    Abstract: Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: March 6, 2018
    Assignee: WISTA LABORATORIES LTD.
    Inventors: Colin Marshall, Scott Clunas, John Mervyn David Storey, James Peter Sinclair, Thomas Craven Baddeley, Ahtsham Ishaq, Michael Simpson, Craig Williamson, Barry Alan Wood, Claude Michel Wischik, Charles Robert Harrington, Janet Elizabeth Rickard, David Horsley, Yin Sze Loh, Karrar Ahmad Khan, Christopher Paul Larch
  • Patent number: 9882990
    Abstract: Systems, methods, and software are disclosed herein for enhancing ad-hoc online meetings. A service client, when executed by a computing system, directs the computing system to at least detect an in-room discovery signal, identify a room from the in-room discovery signal, identify a session based on the room associated with the in-room discovery signal, and join the session.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: January 30, 2018
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Ross Garrett Cutler, Andrew Peter Sinclair, Jonathan Adam Kauffman, Anton Krantz
  • Publication number: 20170342041
    Abstract: Methods of synthesizing and purifying certain 3,7-diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue) are provided.
    Type: Application
    Filed: August 10, 2017
    Publication date: November 30, 2017
    Applicant: WISTA LABORATORIES LTD.
    Inventors: James Peter SINCLAIR, Sarah Louise NICOLL, John Mervyn David STOREY
  • Patent number: 9801890
    Abstract: This disclosure pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7 diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methythioninium Chloride (MTC) (also known as Methylene Blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (NOS); nitrosyl reduction (NR); thiosulfonic acid formation (TSAF); oxidative coupling (OC); Cr(VI) reduction (CR); isolation and purification of zwitterionic intermediate (IAPOZI); ring closure (RC); chloride salt-formation (CSF); one of: sulphide treatment (ST); dimethyldithiocarbamate treatment (DT); carbonate treatment (CT); ethylenediaminetetraacetic acid treatment (EDTAT); organic extraction (OE); and recrystallization (RX). Also disclosed resulting (high purity) compounds, compositions comprising them (e.g.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: October 31, 2017
    Assignee: WISTA LABORATORIES LTD.
    Inventors: John Mervyn David Storey, James Peter Sinclair, Colin Marshall, Han Wan Tan, Claude Michel Wischik
  • Publication number: 20170273986
    Abstract: Disclosed are methods of synthesis and/or purification of certain 3,7-diamino-phenothiazin-5-ium compounds (“diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (Methylene Blue), and the resulting high purity characterized by a purity greater than 98%, and very low levels of heavy metals and organic impurities Azure A, B, C and MVB. Also disclosed are methods of treatment of a tauopathy or methemoglobinemia in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of the high-purity diaminophenothiazinium compound.
    Type: Application
    Filed: June 9, 2017
    Publication date: September 28, 2017
    Applicant: WisTa Laboratories Ltd.
    Inventors: Claude Michel WISCHIK, John Mervyn David STOREY, Colin MARSHALL, James Peter SINCLAIR, Thomas Craven BADDELEY